This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, particularly as a precursor for compounds with potential antidepressant or anxiolytic properties. Its structure, featuring a dichlorophenyl group, allows for specific interactions with biological targets, making it valuable in the design of therapeutic agents. Additionally, it is employed in research settings to study the pharmacological effects of chiral molecules, aiding in the optimization of drug efficacy and safety profiles.